Dear Junobeach,

Thanks for posting your questions on Agoracom.

With regards to your first question:

“Is the Gen 3 machine going to be constructed during the testing taking place on the Gen 2 model or does it have to wait until this testing takes place?”

Yes, the Gen 3 will be fabricated and assemble while Gen 2 testing will be underway.  In fact, we will continue Gen 2 testing while Gen 3 is operational.  This being said, since Gen 2 testing will be starting soon, it’s to our advantage to start final fabrication and assembly of the GEN 3 only after the GEN 2 is operational.

Now regarding the second part of your question:

“Is the hot commissioning on the Gen 3 model still expected to take place in Q1 of 2018?”

I cannot say for definitive at this time, but even if the timing did slip by one-quarter it would not delay the project since we will have the GEN 2 operational this October.  As I have previously stated, what we are doing is unique, the GEN 2 and the GEN 3 are prototypes, so our timing regarding their start dates are really guestimate until the last minute.

This is why I waited so long before giving an update with a start date for the GEN 2.

Regards

Bernard Tourillon
CEO

Disclaimer: This post contains certain forward-looking statements, including, without limitation, statements containing the words "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect", "in the process" and other similar expressions which constitute "forward-looking information" within the meaning of applicable securities laws. Forward-looking statements reflect the Company's current expectations and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Company's ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.